RxDoctor Payments Data

Timothy Coss, DO

Internal Medicine · Columbus, OHNPI 1720071699

Payments from drug & device makers

$8,668in general payments, 2019–2025

Across 577 payments — averaging $15.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$1K
  • AstraZeneca$829
  • Pfizer$772
  • Lilly USA, LLC$670
  • Amgen$560
  • plus $4K from 38 others

What the payments were for

  • Food & beverage$8,626100%
  • Education$420%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,668 in reported general payments places this provider in the 90th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$150,618
Medicare patients
222
Services billed
4,853

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban70$91,856
JardianceEmpagliflozin50$76,180
TrulicityDulaglutide43$66,401
FarxigaDapagliflozin Propanediol26$40,251
XareltoRivaroxaban29$38,474
OzempicSemaglutide22$34,509
MounjaroTirzepatide20$32,666
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$9,099
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$8,425
ShingrixVaricella-Zoster Ge/As01b/Pf21$4,644
SynthroidLevothyroxine Sodium71$4,409
Atorvastatin Calcium485$3,592
Oxcarbazepine13$2,996
Metoprolol Succinate191$2,665
Losartan Potassium297$2,615

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$670$99,06763 claims
PfizerEliquis$772$91,85670 claims
Boehringer IngelheimJardiance$165$76,18050 claims
AstraZenecaFarxiga, Breztri Aerosphere$829$48,67737 claims
Johnson & JohnsonXarelto$219$38,47429 claims
Novo NordiskOzempic$1,204$34,50922 claims
GSKTrelegy Ellipta, Shingrix$403$13,74232 claims
AbbVieSynthroid$1,115$4,40971 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →